Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Daiichi Sankyo Pharma Partnering Guide' returned 6 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Antibiotics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2010, Pages: 850 key and niche players such as Abbott Laboratories, Astellas Pharma, Inc., Bayer HealthCare AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Eli Lilly and Co The Central Nervous Systems Market 2010 Report   NeuroInsights, May 2010 Cypress Bioscience Cytos Cytox D D-Pharm Daiichi Sankyo Dainippon Dakim DarPharma Dart Neuroscience Debiopharm DeCODE Genetics DiaGenic Dianippon DNATraits Domain Therapeutics Douglas The Neurotechnology Industry 2011 Report   NeuroInsights, May 2011, Pages +: 500 in the United States 3: Neuropharmaceutical Sector Neuropharmaceutical Sector Overview Trends in Neuropharmaceuticals Spotlight on Big Pharma Neuropharmaceutical Partnering and Licensing Neurology Markets Biopharmaceuticals - A Global Market Overview   Industry Experts, April 2010, Pages: 240 Limited (India) Bukwang Pharma (South Korea) CellResearchCorp (Singapore) Cipla Ltd (India) Da An Gene Co., Ltd (China) Daiichi Sankyo Ltd. (Japan) Dr. Reddy's Laboratories (India) Glenmark Pharmaceuticals World Pharmaceutical Market Analysis - A Digest Guide, 2010-2014   Venn Research Inc., Aug 2010, Pages: 435 Aspen Pharmacare Holdings Ltd Astellas Pharma AstraZeneca PLC The Menarini Group Cipla Ltd Daiichi Sankyo Co., Ltd. EGIS Pharmaceuticals Plc Eli Lilly and Company Gedeon Richter Ltd GlaxoSmithKline Plc Nuclear Medicine - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2010, Pages: 278 44 Daiichi Sankyo Takes Over U3 Pharma 44 NT Holding Acquires Health Source Technologies 45 Takeda Pharmaceuticals Takes Over Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network